Category:
Biocatalysts
CAS NO:
1355049-92-1
Standard:
In-house Standards,
Huateng Pharmaceutical, a global supplier of pharmaceutical intermediates, offers Remdesivir intermediates CAS NO. 1355049-92-1, Remdesivir Chloro compound for your requirements of R&D, evaluation, pilots and commercial along with supportive technical package required for evaluation
Remdesivir, also known as GS-5734, is a novel antiviral drug in the class of nucleotide analogs developed by Gilead Sciences. In February 2020 Remdesivir was being studied for experimental treatment of the emergent COVID-19 (novel coronavirus) disease.